Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
Martina Morokutti-Kurz,
Affiliation Marinomed Biotech AG, Korneuburg, Austria ⨯
Maria Fröba,
Affiliation Institute of Virology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany ⨯
Philipp Graf,
Affiliation Marinomed Biotech AG, Korneuburg, Austria ⨯
Maximilian Große,
Affiliation Institute of Virology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany ⨯
Andreas Grassauer,
Affiliation Marinomed Biotech AG, Korneuburg, Austria ⨯
Janina Auth,
Affiliation Institute of Virology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany ⨯
Ulrich Schubert,
Affiliation Institute of Virology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany ⨯
Eva Prieschl-Grassauer Roles Conceptualization, Data curation,
Global interest in immune supplements reached unprecedented heights during 2020. The emergence of the COVID-19 pandemic resulted in increased consumer interest in immune health. Along with a focus on nutritious eating and exercise came a significant rise in the intake of immune-supporting dietary supplements.
1
There has been an overwhelming focus on ingredients targeting immune function. Particular interest is being observed in natural ingredients that are backed by credible scientific evidence. One such example is fucoidan, a bioactive polysaccharide found naturally in the cell walls of brown seaweeds. High purity, certified organic fucoidans are well known for their beneficial effects in a range of human health conditions. Understandably, the focus on the immune health evidence supporting this innovative marine compound has intensified over the past 12 months. There has been particular interest in the growing body of research supporting the Maritech brand of fucoidan - the